Article(id=1242136639531721232, tenantId=1146029695717560320, journalId=1146031591421210625, issueId=1242136620485390770, articleNumber=null, orderNo=15, doi=10.3981/j.issn.1000-7857.2018.01.013, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=1512835200000, receivedDateStr=2017-12-10, revisedDate=1514217600000, revisedDateStr=2017-12-26, acceptedDate=null, acceptedDateStr=null, onlineDate=1517280944120, onlineDateStr=2018-01-30, pubDate=1515772800000, pubDateStr=2018-01-13, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1517280944120, onlineIssueDateStr=2018-01-30, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1774078052644, creator=sys-migrate, updateTime=1774078052644, updator=sys-migrate, issue=Issue{id=1242136620485390770, tenantId=1146029695717560320, journalId=1146031591421210625, year='2018', volume='36', issue='1', pageStart='1', pageEnd='212', issueExtLink='null', onlineDate='null', pubDate='null', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=3, issueType=-1, specialIssue=null, createTime=1774078048102, creator=sys-migrate, updateTime=1774078048102, updator=sys-migrate, preIssue=null, nextIssue=null, ext=null, issueFiles=null}, startPage=110, endPage=115, ext={EN=ArticleExt(id=1242136642996220436, articleId=1242136639531721232, tenantId=1146029695717560320, journalId=1146031591421210625, language=EN, title=Review of cancer treatment hot spots in 2017, columnId=1242135221613703813, journalTitle=Science & Technology Review, columnName=Special lssues, runingTitle=null, highlight=null, articleAbstract=In 2017, newly approved therapies brought hope to the treatment of cancers. These included the CD19 CAR-T therapies for patients with B-cell precursor acute lymphoblastic leukemia (ALL) that is refractory or relapsed, and additional indications for checkpoint inhibitors to treat solid tumors. It is worth noting that, for the first time in the FDA history, a treatment (anti-PD-1 antibody Keytruda) was approved to treat patients with unresectable or metastatic solid tumors as long as the tumor is positive for a biomarker referred to as microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR). Progresses were also made in targeted therapies. For example, the FLT3 mutant inhibitor, in combination with chemotherapy, was approved as the first new treatment for acute myeloid leukemia (AML) in more than 25 years. The review focuses on the new therapies, either approved or showing great promise in clinical trials, which may change the paradigm of cancer therapies., correspAuthors=null, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=apG4lv08l0rhWl46n5ZU5w==, pdfFileSize=1310097, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, authorCompany=Pathology and Laboratory Medicine, Perelman School of Medicine, Philadelphia 19104, USA, fund=null, authors=ZHANG Hongtao, authorsList=ZHANG Hongtao), CN=ArticleExt(id=1242136641884729870, articleId=1242136639531721232, tenantId=1146029695717560320, journalId=1146031591421210625, language=CN, title=免疫治疗现重要突破,靶向药物创历史进展——2017年癌症治疗热点回眸, columnId=1242116902361830275, journalTitle=科技导报, columnName=专题论文, runingTitle=null, highlight=null, articleAbstract=癌症治疗在2017年迎来了一系列新的希望,其中最为重要的是CAR-T治疗的正式登场,两种靶向CD19的CAR-T细胞获得对复发性/难治性B细胞急性淋巴细胞白血病以及大B细胞淋巴癌治疗的批准。同时,免疫检查点抑制剂也获得更多实体瘤适应症的批准,尤其是将MSI-H或dMMR作为生物标志物,作为临床治疗的指导。在靶向治疗方面,一些新的药物获得批准,比如FLT3突变抑制剂Midostaurin与化疗的联合使用,是25年来FDA首次批准的AML新药。此外,在临床研究中也出现一些比较激动人心的结果,癌症疫苗在黑色素瘤的治疗中获得了突破。本文将对这些热点研究结果进行回顾性综述。, correspAuthors=null, authorNote=张洪涛,研究副教授,研究方向为癌症靶向治疗、免疫治疗,电子信箱:zhanghon@mail.upenn.edu, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=+KEtbgNtGCSr+DHBgYalZA==, pdfFileSize=1310097, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, authorCompany=宾夕法尼亚大学医学院病理及实验医学系, 美国费城 19104, fund=NIH grant (U01CA168925,1R01HL128895-03);DOD IDEA grant (W81XWH-15-1-0362), authors=张洪涛, authorsList=张洪涛)}, authors=null, keywords=[Keyword(id=1242136640869708293, tenantId=1146029695717560320, journalId=1146031591421210625, articleId=1242136639531721232, language=CN, orderNo=1, keyword=CAR-T), Keyword(id=1242136640949400070, tenantId=1146029695717560320, journalId=1146031591421210625, articleId=1242136639531721232, language=CN, orderNo=1, keyword=免疫检查点抑制剂), Keyword(id=1242136641029091848, tenantId=1146029695717560320, journalId=1146031591421210625, articleId=1242136639531721232, language=CN, orderNo=1, keyword=癌症疫苗), Keyword(id=1242136641201058314, tenantId=1146029695717560320, journalId=1146031591421210625, articleId=1242136639531721232, language=CN, orderNo=1, keyword=肿瘤新抗原), Keyword(id=1242136641276555788, tenantId=1146029695717560320, journalId=1146031591421210625, articleId=1242136639531721232, language=CN, orderNo=1, keyword=靶向治疗), Keyword(id=1242136642501292559, tenantId=1146029695717560320, journalId=1146031591421210625, articleId=1242136639531721232, language=EN, orderNo=1, keyword=CAR-T), Keyword(id=1242136642572595728, tenantId=1146029695717560320, journalId=1146031591421210625, articleId=1242136639531721232, language=EN, orderNo=1, keyword=immunoassay point inhibitor), Keyword(id=1242136642656481809, tenantId=1146029695717560320, journalId=1146031591421210625, articleId=1242136639531721232, language=EN, orderNo=1, keyword=cancer vaccine), Keyword(id=1242136642740367890, tenantId=1146029695717560320, journalId=1146031591421210625, articleId=1242136639531721232, language=EN, orderNo=1, keyword=neoplastic antigen), Keyword(id=1242136642828448275, tenantId=1146029695717560320, journalId=1146031591421210625, articleId=1242136639531721232, language=EN, orderNo=1, keyword=targeted therapy)], refs=null, funds=null, companyList=null, figs=null, attaches=null, journal=Journal(id=1125356956822126595, delFlag=0, nameCn=科技导报, nameEn=Science & Technology Review, nameHistory1=null, nameHistory2=null, issn=1000-7857, eissn=, cn=11-1421/N, coden=null, periodic=3, language=CN, oaType=0, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=aEuqdCNQUjPEKa3rm5A/8Q==, journalPrice=null, startedYear=null, abbrevIsoEn=Sci Technol Rev, journalRemark=null, publicationField=null, createdTime=null, updatedTime=1754267492363, createdBy=null, updatedBy=13701087609, firstLetterCn=S, firstLetterEn=S, subjectCode=Natural Sciences, subjectName=自然科学, subjectCodeEn=Natural Sciences, subjectNameEn=null, picCn=aEuqdCNQUjPEKa3rm5A/8Q==, picEn=4AIQ9/oc3H8lvjeELJ6WWw==, jcr=null, cjcr=null, exts=[JournalExt(id=1159045127382855686, language=CN, name=科技导报, nameHistory1=null, nameHistory2=null, managedBy=中国科学技术协会, sponsoredBy=中国科学技术协会, publishedBy=科技导报社, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=null, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=http://www.kjdb.org/CN/home, createdTime=1754267492385, updatedTime=1754267492385, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=http://www.kjdb.org/CN/column/column7.shtml, submissionAuthorUrl=https://kjdbauthor.cast.org.cn/webm, submissionEditorUrl=https://kjdbeditor.cast.org.cn/webm/, submissionReviewUrl=https://kjdbauthor.cast.org.cn/webm, submissionCeEditorUrl=https://kjdbeditor.cast.org.cn/webm/, submissionAeEditorUrl=https://kjdbeditor.cast.org.cn/webm/, option={"copyright":""}), JournalExt(id=1159045127433187335, language=EN, name=Science & Technology Review, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=null, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=http://www.kjdb.org/EN/home, createdTime=1754267492398, updatedTime=1754267492398, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=http://www.kjdb.org/EN/column/column7.shtml, submissionAuthorUrl=https://kjdbauthor.manuscriptcloud.com/login, submissionEditorUrl=https://kjdbeditor.manuscriptcloud.com/login, submissionReviewUrl=https://kjdbauthor.manuscriptcloud.com/login, submissionCeEditorUrl=https://kjdbeditor.manuscriptcloud.com/login, submissionAeEditorUrl=https://kjdbeditor.manuscriptcloud.com/login, option={"copyright":""})], databaseList=null, tenantJournalId=1146031591421210625, websiteList=[Website(id=1146104741081231361, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1146031591421210625, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/kjdb/CN, language=CN, createTime=1751182263881, createBy=18614031015, updateTime=1751778001962, updateBy=18614031015, name=科技导报, tplId=1146099689490845704, title=科技导报, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1148021146403992296, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1146104741081231361, code=articleTextType, value=kx, createTime=1751639170504, updateTime=1751639170504, creator=18614031015, updator=18614031015), WebsiteProps(id=1148021146378826469, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1146104741081231361, code=banner, value=null, createTime=1751639170498, updateTime=1751639170498, creator=18614031015, updator=18614031015), WebsiteProps(id=1148021146366243556, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1146104741081231361, code=logo, value=https://castjournals.cast.org.cn/joweb/kjdb/CN/file/pic?fileId=9GHSf7eGlIPH0Tv/OOdstA==, createTime=1751639170495, updateTime=1751639170495, creator=18614031015, updator=18614031015), WebsiteProps(id=1148021146395603687, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1146104741081231361, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/kjdb/CN/file/pic, createTime=1751639170502, updateTime=1751639170502, creator=18614031015, updator=18614031015), WebsiteProps(id=1148021146387215078, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1146104741081231361, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1751639170500, updateTime=1751639170500, creator=18614031015, updator=18614031015)]), Website(id=1146105254833139715, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1146031591421210625, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/kjdb/EN, language=EN, createTime=1751182386363, createBy=18614031015, updateTime=1753500121937, updateBy=18614031015, name=科技导报, tplId=1146101810881728533, title=Science & Technology Review, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1155838567709528217, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1146105254833139715, code=articleTextType, value=kx, createTime=1753502988984, updateTime=1753502988984, creator=18614031015, updator=18614031015), WebsiteProps(id=1155838567692750998, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1146105254833139715, code=banner, value=null, createTime=1753502988980, updateTime=1753502988980, creator=18614031015, updator=18614031015), WebsiteProps(id=1155838567688556693, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1146105254833139715, code=logo, value=https://castjournals.cast.org.cn/joweb/kjdb/EN/file/pic?fileId=9GHSf7eGlIPH0Tv/OOdstA==, createTime=1753502988979, updateTime=1753502988979, creator=18614031015, updator=18614031015), WebsiteProps(id=1155838567705333912, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1146105254833139715, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/kjdb/EN/file/pic, createTime=1753502988983, updateTime=1753502988983, creator=18614031015, updator=18614031015), WebsiteProps(id=1155838567701139607, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1146105254833139715, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1753502988982, updateTime=1753502988982, creator=18614031015, updator=18614031015)])], journalTitle=科技导报, weixinUrl=null, journalUrl=null, iacademicId=null, status=0, seqNo=null, journalTitleEn=Science & Technology Review, journalPhotoCn=aEuqdCNQUjPEKa3rm5A/8Q==, journalPhotoEn=4AIQ9/oc3H8lvjeELJ6WWw==, journalFirstLetter=S, journalRecommend=null, journalNew=null, journalCollection=1, jcrJf=null, cjcrJf=0.91, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=null, provinceCode=null, provinceName=null, collectFlag=false), detailUrlCn=https://castjournals.cast.org.cn/joweb/kjdb/CN/10.3981/j.issn.1000-7857.2018.01.013, detailUrlEn=https://castjournals.cast.org.cn/joweb/kjdb/EN/10.3981/j.issn.1000-7857.2018.01.013, pdfUrlCn=https://castjournals.cast.org.cn/joweb/kjdb/CN/PDF/10.3981/j.issn.1000-7857.2018.01.013, pdfUrlEn=https://castjournals.cast.org.cn/joweb/kjdb/EN/PDF/10.3981/j.issn.1000-7857.2018.01.013, aliStartDate=null, aliEndDate=null, collectionFlag=false, citedCount=null, citedUrl=null, reference=null)
科技导报
| 专题论文 2018, 36(1): 110-115
免疫治疗现重要突破,靶向药物创历史进展——2017年癌症治疗热点回眸
全屏
张洪涛
作者信息
宾夕法尼亚大学医学院病理及实验医学系, 美国费城 19104
Review of cancer treatment hot spots in 2017
Affiliations
出版时间: 2018-01-13
doi: 10.3981/j.issn.1000-7857.2018.01.013
文章导航
癌症治疗在2017年迎来了一系列新的希望,其中最为重要的是CAR-T治疗的正式登场,两种靶向CD19的CAR-T细胞获得对复发性/难治性B细胞急性淋巴细胞白血病以及大B细胞淋巴癌治疗的批准。同时,免疫检查点抑制剂也获得更多实体瘤适应症的批准,尤其是将MSI-H或dMMR作为生物标志物,作为临床治疗的指导。在靶向治疗方面,一些新的药物获得批准,比如FLT3突变抑制剂Midostaurin与化疗的联合使用,是25年来FDA首次批准的AML新药。此外,在临床研究中也出现一些比较激动人心的结果,癌症疫苗在黑色素瘤的治疗中获得了突破。本文将对这些热点研究结果进行回顾性综述。
CAR-T
/
免疫检查点抑制剂
/
癌症疫苗
/
肿瘤新抗原
/
靶向治疗
In 2017, newly approved therapies brought hope to the treatment of cancers. These included the CD19 CAR-T therapies for patients with B-cell precursor acute lymphoblastic leukemia (ALL) that is refractory or relapsed, and additional indications for checkpoint inhibitors to treat solid tumors. It is worth noting that, for the first time in the FDA history, a treatment (anti-PD-1 antibody Keytruda) was approved to treat patients with unresectable or metastatic solid tumors as long as the tumor is positive for a biomarker referred to as microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR). Progresses were also made in targeted therapies. For example, the FLT3 mutant inhibitor, in combination with chemotherapy, was approved as the first new treatment for acute myeloid leukemia (AML) in more than 25 years. The review focuses on the new therapies, either approved or showing great promise in clinical trials, which may change the paradigm of cancer therapies.
CAR-T
/
immunoassay point inhibitor
/
cancer vaccine
/
neoplastic antigen
/
targeted therapy
张洪涛.
免疫治疗现重要突破,靶向药物创历史进展——2017年癌症治疗热点回眸.
科技导报,
2018
, 36
(1)
: 110
-115
.
DOI: 10.3981/j.issn.1000-7857.2018.01.013
ZHANG Hongtao.
Review of cancer treatment hot spots in 2017[J].
Science & Technology Review ,
2018
, 36
(1)
: 110
-115
.
DOI: 10.3981/j.issn.1000-7857.2018.01.013
2018年第36卷第1期
PDF下载
318
115
引用本文
BibTeX
文章信息
doi: 10.3981/j.issn.1000-7857.2018.01.013
接收时间:2017-12-10
首发时间:2018-01-30
出版时间:2018-01-13
收稿日期:2017-12-10
修回日期:2017-12-26
https://castjournals.cast.org.cn/joweb/kjdb/CN/10.3981/j.issn.1000-7857.2018.01.013
复制链接
引用本文
BibTeX
2种不同金属材料的力学参数
科 Family 属数 Number of genus 种数 Number of species 占总种数比例 Percentage of total species (%) 属 Genus 种数 Number of species 占总种数比例 Percentage of total species (%) 鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78 小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39 多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39 红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87 小菇属 Mycena 11 5.26 光柄菇属 Pluteus 5 2.39 红菇属 Russula 17 8.13 栓菌属 Trametes 5 2.39
关闭全屏
BibTeX
EndNote
RefWorks
TxT